What is lifileucel?
The immune system plays an important role in helping to keep the body healthy and free from diseases such as infections and cancer.
When cancer is detected, it naturally responds by sending specialized immune cells known as T cells.
The investigational TIL cell therapy process with lifileucel multiplies a patient’s unique T cells to create the one-time treatment that may help fight cancers that are unresectable (cannot be removed with surgery) or metastatic (have spread to a different body part).
TIL=tumor infiltrating lymphocytes.
How is investigational TIL cell therapy made?
Lifileucel is a one-time investigational TIL cell therapy that takes about 1 month to make.
Investigational TIL cell therapy is an individualized approach:
Removing tumor tissue
A small piece of the patient’s tumor is surgically removed and shipped to a specialized manufacturing facility
Separating T cells
At the specialized facility, the patients T cells are separated from the tumor
Multiplying T cells
The separated T cells are rejuvenated and grown into the billions
Lifileucel
These steps—when completed—will produce the one-time investigational TIL cell therapy lifileucel
Learn how investigational TIL cell therapy is designed to work
This website is intended for a U.S. audience. TIL cell therapy is not yet approved by any regulatory or health agency for the investigational uses described in this website. This website is for educational purposes only and is not intended to replace discussions with a healthcare professional.
